Fort Lee, NJ -- October 27, 2005 -- It is estimated that eighty percent of the 10 million Americans suffering from both diabetes and hypertension do not reach goal blood pressure (BP) and are at increased risk for heart, kidney and eye disease. Now, an already available non-drug hypertension treatment device, named RESPeRATE (www.RESPeRATE.com), has demonstrated its ability to significantly lower blood pressure in this specific population.

An interim analysis of the results of the first 38 patients participating in a randomized controlled study of non-insulin-dependent diabetics with uncontrolled blood pressure was presented recently at the European General Practice Research Network meeting. The study, conducted by Dr. Moshe Schein from the HadassahHebrew University Medical Center in Jerusalem, Israel, compared the BP response to 8 weeks of 15-minute daily self-treatment with device-guided slow breathing using the RESPeRATE device with that of a control group that continued their usual care. Medication, diet and physical exercise were unchanged in both groups during the study.

Results show a significant reduction in systolic blood pressure (SBP) of 7.4 mmHg in the treatment group, compared to a rise of 3.1 mmHg in the control group (P<0.005). Thirty-two percent of the RESPeRATE-treated patients reached the target BP of 130/80 mmHg compared with just 5% in the control group (p<0.05). No side effects were observed and compliance with treatment was good. Similar to the previous seven published RESPeRATE studies, which were performed in general hypertensive populations, this study also demonstrated a dose-response relationship. Performing more breathing exercise sessions with RESPeRATE, increased the reduction of systolic blood pressure (p<0.005).

"This is fantastic news for the diabetes community and for InterCure" said Erez Gavish, President & CEO of InterCure, the developer of RESPeRATE. "Diabetes treatment
'"/>

Contact: Tom Kirwan
tkirwan@intercure.com
347-528-7734
InterCure
27-Oct-2005

Page: 1 2
Related biology news :

1. New approach to pulmonary hypertension shows promise
2. Sleep apnea increases risk of diabetes and hypertension in pregnant women
3. Kent State University and Summa Health System receive NIH grant to study prehypertension
4. Active ingredient in common Chinese herb shown to reduce hypertension
5. Scientific meeting on pulmonary hypertension, December 7-8
6. Lifton honored by two medical societies for work on hypertension
7. Pulmonary hypertension discriminates by race, gender
8. Leveling the field for babies with persistent pulmonary hypertension
9. Low-level exercise delays heart failure, markedly extends lives, even with hypertension
10. Researchers uncover mechanisms leading to portal hypertension
11. First report of cancer drug Gleevec as new target therapy for pulmonary hypertension